Cargando…
Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study)
BACKGROUND: Apart from clinical outcomes, the "real-world" outcomes of intermittent short-course cyclosporine treatment remain poorly documented. OBJECTIVE: To evaluate various outcomes of short-course cyclosporine treatment for severe psoriasis; and to describe dermatologists' use of...
Autores principales: | Swimberghe, Sandra, Ghislain, Pierre-Dominique, Daci, Evis, Allewaert, Katrien, Denhaerynck, Kris, Hermans, Christine, Pacheco, Christy, Vancayzeele, Stefaan, MacDonald, Karen, Abraham, Ivo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582925/ https://www.ncbi.nlm.nih.gov/pubmed/23467644 http://dx.doi.org/10.5021/ad.2013.25.1.28 |
Ejemplares similares
-
Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
por: Van Gaal, Luc, et al.
Publicado: (2019) -
Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study
por: Rakic, Jean-Marie, et al.
Publicado: (2013) -
Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Hypertensive Patients with and without Diabetes: Pooled Analysis of Six Observational Valsartan Studies with 15,282 Evaluable Patients
por: Ashy, Noha, et al.
Publicado: (2017) -
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program
por: Abraham, Ivo, et al.
Publicado: (2011) -
Variability in total serum IgE over 1 year in severe asthmatics
por: Louis, Renaud, et al.
Publicado: (2019)